Synairgen Plc

Synairgen PLC is a clinical-stage biotechnology UK-based company focused on developing novel inhaled treatments for respiratory diseases. Its primary aim is to improve outcomes for patients suffering from severe viral lung infections and chronic lung conditions. The company's research targets global health challenges. Operating within the biotechnology and pharmaceutical sector, Synairgen PLC specialises in therapies designed to be delivered directly to the lungs. The company's innovative approach seeks to provide treatments that reduce the severity of respiratory illnesses and enhance patient recovery. Explore SNG.L share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.